【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 6
2 Introduction 7
2.1 Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) Overview 7
3 Products under Development 8
3.1 PTA Peripheral Drug Eluting Balloons (DEB) – Pipeline Products by Stage of Development 8
3.2 PTA Peripheral Drug Eluting Balloons (DEB) – Pipeline Products by Territory 9
3.3 PTA Peripheral Drug Eluting Balloons (DEB) – Pipeline Products by Regulatory Path 11
3.4 PTA Peripheral Drug Eluting Balloons (DEB) – Pipeline Products by Estimated Approval Date 13
3.5 PTA Peripheral Drug Eluting Balloons (DEB) – Ongoing Clinical Trials 14
4 PTA Peripheral Drug Eluting Balloons (DEB) – Pipeline Products under Development by Companies 15
4.1 PTA Peripheral Drug Eluting Balloons (DEB) Companies – Pipeline Products by Stage of Development 15
4.2 PTA Peripheral Drug Eluting Balloons (DEB) – Pipeline Products by Stage of Development 16
5 PTA Peripheral Drug Eluting Balloons (DEB) Companies and Product Overview 17
5.1 AnGes MG, Inc. Company Overview 17
5.1.1 AnGes MG, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 AngioCure, Inc. Company Overview 19
5.2.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 AVIDAL Vascular GmbH Company Overview 20
5.3.1 AVIDAL Vascular GmbH Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Bayer HealthCare AG Company Overview 21
5.4.1 Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 C. R. Bard, Inc. Company Overview 24
5.5.1 C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Contego Medical, LLC Company Overview 28
5.6.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 eucatech AG Company Overview 29
5.7.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Eurocor GmbH Company Overview 30
5.8.1 Eurocor GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 Genesis Technologies, Inc (Inactive) Company Overview 34
5.9.1 Genesis Technologies, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 35
5.10.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 Micell Technologies, Inc. Company Overview 36
5.11.1 Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 Minvasys Company Overview 38
5.12.1 Minvasys Pipeline Products & Ongoing Clinical Trials Overview 38
5.13 Neovasc Inc. Company Overview 40
5.13.1 Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.14 Nipro Corporation Company Overview 42
5.14.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
5.15 QT Vascular Ltd. Company Overview 44
5.15.1 QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
5.16 Rontis AG Company Overview 47
5.16.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 47
5.17 SiL Vascular Ltd Company Overview 48
5.17.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.18 SurModics, Inc. Company Overview 49
5.18.1 SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.19 Terumo Corporation Company Overview 51
5.19.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 The Spectranetics Corporation Company Overview 53
5.20.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 53
5.21 Vascular Nanotransfer Technologies Company Overview 57
5.21.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 57
6 PTA Peripheral Drug Eluting Balloons (DEB)- Recent Developments 59
7 Appendix 77
7.1 Methodology 77
7.2 About GlobalData 79
7.3 Contact Us 80
7.4 Disclaimer 80
【レポート販売概要】
■ タイトル：世界における末梢経管形成薬剤溶出バルーン（DEB）の製品パイプライン動向2015■ 英文：Peripheral Transluminal Angioplasty Drug Eluting Balloons (DEB) - Pipeline Review, 2015
■ 発行日：2015年7月28日
■ 調査会社：GlobalData
■ 商品コード：GDME0054EPD
■ 調査対象地域：グローバル
- Questar Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Questar Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Questar Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 電子ペーパー用ディスプレイの世界市場2016-2020[Global E-Paper Display Market 2016-2020] Covering: This market research report includes a detailed segmentation of the global E-paper display market by application (E-book reader, mobile displays, public displays, wearable technology, and retail) and by technology (flat screen, curved screen, bendable screens, and foldable screens). It outlines the market shares for key regions such as the Americ …
- 自動車アクスル（車軸）及びプロペラシャフトの世界市場：ライブ車軸、固定車軸、タンデム車軸、フロント/リア/車軸間プロペラシャフトThe demand for automotive axles and propeller shafts is governed by global vehicle production. Axles are designed to bear the weight of the vehicle, and are required to be lightweight for fuel-efficiency and structurally stiff to handle the vehicle’s powertrain requirements given the increased torque. Tier I suppliers are developing new technologies, focusing on reduction of fuel consumption. Supp …
- ハードコーティング（硬質被膜）の世界市場予測：窒化物、酸化物、ホウ化物、炭素系、カーバイドThe global market size for hard coatings is projected to reach USD 1,351.3 Million by 2026, at a CAGR of 8.0% during the forecast period. The market is driven by rise in demand in the Asia-Pacific region, increase in awareness about the benefits of hard coatings, and emerging automotive and healthcare sectors. General manufacturing is one of the major markets for hard coatings in developing as wel …
- 麻酔深度モニタリングの世界市場予測（～2024年）“Increasing number of surgeries in the US to drive the overall growth of the US depth of anesthesia monitoring market” The US depth of anesthesia monitoring market is projected to grow from USD 141 million in 2018 to USD 170 million by 2024, at a CAGR of 3.2% during the forecast period. The increasing number of surgeries and rising patient volume in hospitals in the US are the major factors drivin …
- Non-Alcoholic Steatohepatitis：グローバル臨床試験レビューH1, 2013Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2013" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Alcoholic Steatohepatitis. It includes an overv …
- エンタープライズモビリティ管理ソリューションの世界市場：モバイルデバイス管理、モバイルコンテンツ管理、モバイルアプリケーション管理Enterprise Mobility Management (EMM) can be defined as the process that enables enterprises to remodel their present architecture to build more proficient and advanced systems that can allow more flexible, secure, and mobile workforce. The EMM market is segmented by solution and service. The solutions have been further segmented by type of device and operating system. The overall market size of EM …
- テレコム向けクラウドの世界市場予測（～2021）：種類別（ソリューション、サービス）、用途別、サービスモデル別、企業規模別、産業別、地域別“Growing awareness about telecom cloud among enterprises and the need for low operational and administration costs are expected to drive the overall telecom cloud market” The telecom cloud market size is estimated to grow from USD 10.92 billion in 2016 to USD 30.79 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 23.0%, due to the need for low operational and administration costs & the …
- 垂直農法の世界市場予測（～2022）：栽培方法別（水耕栽培、空中栽培、アクアポニックス）、構造別、提供方法別、作物種類別、地域別According to the new market research report, the vertical farming market is expected to be valued at USD 5.80 Billion by 2022, growing at a CAGR of 24.8% between 2016 and 2022. The growth of the vertical farming market could be attributed to the growing urbanization, rising demand for high quality food with no use of pesticides and herbicides, and independent farming technique with low impact of c …
- 航空貨物の世界市場2015-2019About Air Cargo Air cargo services include the shipment of all kinds of goods by the air to both international and domestic customers at competitive rates. Such services are provided by air cargo companies, which arrange for the transfer, customs clearance, and tracking of consignments. The cargo is transported by passenger aircraft and charter aircraft. Air cargo companies or freight forwarders p …
- 麦芽飲料（Malt Beverage）のグローバル市場Summary Malt beverages (non-alcoholic) are an increasingly important element within the global beverage spectrum. This report defines what they are and focuses on three key regions, MENA, Latin America and the Caribbean and Africa. The report provides a global view of malt beverages, their consumption and positioning followed by consideration and characterization of each region before focusing on …
- コンシューマIAM（アイデンティティ・アクセス管理）の世界市場予測（～2022年）The consumer Identity and Access Management (IAM) market size is expected to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 17.3% during the forecast period. The major growth drivers of the consumer IAM market include growing concern to manage consumer identity, rise in adoption of Internet of Things (IoT) and smart devices, and need fo …
- 世界の食品接触紙（食品包装用）市場（2014-2018）About Food Contact Paper Food contact paper is commonly used for food packaging, for example, for bakery products, fruits, liquids and beverages, and takeout food. It can be segmented according to paper type: 72.3 percent of food contact paper is non-poly-coated and used for packaging dry food items compared to 27.7 percent that is poly-coated and used for packaging liquids , food, and beverages. …
- 世界のヘルスケアにおけるIoT市場：コンポーネント別（医療機器、システム＆ソフトウェア、サービス、接続技術）、用途別（テレメディシン、コネクテッドイメージング、入院患者モニタリング）、エンドユーザー別、地域別The global Internet of Things (IoT) in healthcare market size to grow at a CAGR of 27.6% during the forecast period The IoT in healthcare market size is projected to grow from USD 55.5 billion in 2019 to USD 188.0 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 27.6% during the forecast period. The IoT in healthcare market is driven by factors, such as advancement in technology coupled …
- 主要先進国における乳癌治療市場（～2020）Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs Summary GBI Research, the leading business intelligence provider, has released its latest research, '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs'’, whi …
